Search
Etuvetidigene Autotemcel
go.drugbank.com/drugs/DB17593ApprovedInvestigational[L54693] WAS is a rare X-linked disorder caused by a mutation in the gene encoding the WAS protein, leading to a compromised immune system. … [L54698] First approved by the FDA on December 9, 2025, etuvetidigene autotemcel is used to treat Wiskott–Aldrich syndrome (WAS) in selected pediatric and adult patients.
Bacitracin
go.drugbank.com/drugs/DB00626ApprovedInvestigationalVet approvedBacitracin is a combination of at least 9 bacitracins. 60-80% of commercially prepared bacitracin is bacitracin A. The bacillus that produces bacitracin was first isolated from a knee scrape in 1945 from the knee wound of a child named M...
Mixtures: Zee 3-in-One First Aid Antibiotic, Neosporin Plus Pain Relief Neo to GoProducts: Bacitracin Zinc Granula 15% W/W, YH Bacitracin Zinc 15% W/W PowderHydrogen peroxide
go.drugbank.com/drugs/DB11091ApprovedInvestigationalVet approvedIf heated to its boiling point, it may undergo potentially explosive thermal decomposition. … Hydrogen peroxide is formed in the body of mammals during reduction of oxygen either directly in a two-electron transfer reaction [L2024].
Mixtures: Medi W ToothProducts: Psp Go, Wellmex Hydrogen Peroxide 6% w/v SolutionButylamine
go.drugbank.com/drugs/DB03659ExperimentalIt is one of the four isomeric amines of butane. It is known to have the fishy, ammonia-like odor common to amines.
Sincalide
go.drugbank.com/drugs/DB09142ApprovedThe evacuation of bile that results is similar to that which occurs physiologically in response to endogenous cholecystokinin. … Sincalide is a medication given by injection to assist in the diagnosis of gallbladder and pancreas disorders.
Mecasermin
go.drugbank.com/drugs/DB01277ApprovedInvestigationalThe amino acid sequence of the product is identical to that of endogenous human IGF-1.
Clesrovimab
go.drugbank.com/drugs/DB18877Approvedto provide passive immunization against RSV infection as an alternative means of protection. … [A273953,A273978] Clesrovimab-cfor was approved by the US FDA in June 2025 for use in infants prior to or during their first RSV season.[L53228,L53233]
Ceritinib
go.drugbank.com/drugs/DB09063ApprovedInvestigationalThis occurrence led to development of novel second-generation ALK inhibitors such as ceritinib to overcome crizotinib resistance. … carcinogenesis and seems to drive the malignant phenotype.
Etanercept
go.drugbank.com/drugs/DB00005ApprovedInvestigationalDimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. … It is used to treat or manage a variety of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis (AS), and juvenile idiopathic poly-articular arthritis (JIA).